I wrote about Chemours a few months back, calling the company a "BUY" - shortly after that, the market dropped, and the company is down significantly more today. While it remains impossible to forecas
While Chemours (CC) is exposed to supply-chain issues and higher input costs, it gains on healthy demand, strong execution and its cost-reduction and pricing actions.

Why Shares of Chemours Plummeted This Week

03:30pm, Friday, 23'rd Sep 2022
The company's bottom line in 2022 may be lower than management originally thought.
Shares of Chemours Co. CC, -5.24% sank 5.5% toward a six-month low in premarket trading Wednesday, after the specialty materials company lowered its full-year outlook due to a continued demand decline
A recovery in demand in major end markets should enable the Zacks Chemicals Diversified industry to thrive. ALB, CC, UNVR and IOSP are set to gain from favorable industry fundamentals and strategic ac
Against the current volatile macroeconomic backdrop, it would be prudent to add some top-quality dividend-paying chemical stocks in your portfolio. CC, CBT, HUN, LYB and TROX fit the bill.

Is Chemours (CC) Stock Undervalued Right Now?

11:17am, Tuesday, 06'th Sep 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
CC vs. PPG: Which Stock Is the Better Value Option?
Chemours (CC) gains on strong end-market demand and its cost-reduction and pricing actions.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
CC vs. PPG: Which Stock Is the Better Value Option?
Here is how Chemours (CC) and Ryerson Holding (RYI) have performed compared to their sector so far this year.
Chemours (CC) gains on healthy demand, strong execution and its cost-reduction and pricing actions.
CNBC's Jim Cramer spoke with Chemours CEO Mark Newman on Thursday's episode of "Mad Money."
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE